D1 2025: our (provisional) answers
Please find below our provisional answers to the D1 questions of the 2025 paper (D1-1, D1-2).
(Note: D2 answer here, first impressions blog here)
QUESTION 1 (8 MARKS)
On 11 November 2024, German applicants A and B jointly filed an international application PCT-AB with the EPO. PCT-AB validly claims priority from an earlier EP application EP-B, filed on 10 November 2023 by applicant B.
The European search report for EP-B cites only A documents.
Today (11 March 2025), A and B wish to delay the entry of PCT-AB into the regional phase before the EPO for as long as possible for strategic reasons.
What steps should be taken and why?
Answer
·
The 31m period for EP entry is
calculated from earliest priority date - R 159(1) EPC.
·
At present, the 31m period will
expire 10/11/2023 + 31m [R 131(4) EPC] --> 10/06/2026 (Wed)
·
To postpone EP entry as far as
possible, the priority claim to EP-B must be withdrawn, as the time limit will then be recalculated from
the new earliest priority date, i.e. the PCT filing date - R. 90bis.3 (d)
·
The applicants must submit a
notice of withdrawal, withdrawing the priory claim under R. 90bis.3 PCT
·
To be submitted to the EPO as
rO or to the IB - R 90bis.3(c)
·
Time limit: can be done at any
time prior to expiry of 30m from priority - R. 90bis.3(a)
·
So until 10/11/2023 + 30m [R.
80.2 PCT] --> 10/05/2026 (Sun) extended to 11/05/2026 [R. 80.5 PCT]
·
The notice of withdrawal must
be signed by both applicants: A and B - R. 90bis.5.
·
Or, if one of the applicants is
the common representative and has been appointed and authorized by the other
applicant under R 90.4, the common representative may sign the notice of
withdrawal.
·
An agent appointed and
authorized via a PoA under R 90bis.4(e) may also sign,
Effect of withdrawal:
·
Time limits are recalculated
based on new earliest priority date, i.e. the PCT filing date - R. 90bis.3 (d)
· So 31m period for entry [R 159(1)] will now expire on 11/11/2024 + 31m --> 11/06/2027
· A further effect of withdrawing the priority claim is that that upon entry into the EP phase, the date for assessing patentability w.r.t. the prior art becomes the PCT filing date.
· If EP-B publishes, it will be novelty destroying 54(3) prior art for Euro-PCT-AB.
· EP-B will publish shortly after 18m from priority - Art 93(1)a on:
10/11/2023 + 18m --> 10/05/2025
· To guarantee non publication, EP must be withdrawn before technical preparations for publication are complete - R 67(2) EPC
· These are deemed complete 5 weeks before exipry of 18m period, so on 5 April 2025 - R 67(1) EPC; OJ 2007, SE3, D.1
· Request for withdrawal, indicating that it is being done to prevent publication, should be submitted on 4 April at the latest, so still time.
· Declaration of withdrawal must be signed by the applicant B, or a professional representative appointed by B, and must be clear - J11/80
· Note: you can further delay the entry by missing the 31m deadline, wait for the loss-of-rights communication -R.160(1), R.112(1)- and then do further processing at the end of the 2m period that runs from the date of the loss-of-rights communication [R.126(2)], where you need to do various omitted acts of R.159(1) (filing fee, examination fee, written request for examination, designation fee) and pay multiple FP fees, and pay the (missed) renewal fee of R.159(1)(g) with 50% additional fee. Whether this was expected to be part of your answer or not is uncertain.
QUESTION 2 (7 MARKS)
On 16 January 2024, applicant C filed patent application
IT-1 in Italian with the Italian patent office. IT-1 claims and describes
invention A. IT-1 was withdrawn shortly after filing, without having been
published. On 17 April 2024, invention A was published in a journal.
On 16 January 2025, applicant C filed application EP-1 with the EPO, claiming priority from IT-1. The filing and search fees were paid on the same day.
On 17 February 2025, applicant C filed application EP-2 in English with the EPO. EP-2 claims and describes invention B. EP-2 does not claim any priority.
Inventions A and B are unrelated.
Today (11 March 2025), applicant C notices that, by
mistake, EP-1 neither claims nor describes invention A but includes the same
description and claims as EP-2.
(a) What should applicant C do to obtain a patent for invention A?
(b) Applicant C additionally wants to prosecute invention B. What needs to be done to obtain a patent on the basis of EP-2?
Answer
(a):
· Invention A described and claimed in IT-1, which is C's first application for A EP-1 filed on last day of 12m priority of IT-1 [Art 87(1) EPC] by same applicant C.
· C may validly claim priority for inv A, but unfortunately wrong application documents have been filed and at present, EP-1 relates to a different invention.
· This can be corrected under R. 56a(4) EPC, since priority of IT-1 was claimed at filing of EP-1.
Actions:
· Within 2m of filing EP-1: 16/01/2025 + 2m [R 131(4)] --> 16/03/2025 (Sun) extended to 17/03/2025 [R. 134(1) EPC], so by 17 March (still time)
·
C must notify the EPO that the
wrong application docs have been filed and request to keep the filing date
using R.56a(4):
·
Provide a copy of IT-1 - R.
56a(4)a
·
Since it was filed in Italian,
a translation must be submitted into EN, FR or DE - R. 56a(4)b
·
The applicant must also
indicate where the correct parts are completely contained in the priority
application, i.e. the complete description and all claims of IT-1.
·
All of these actions must be
taken before 17/03/2025 to ensure that the filing date of EP1
remains 16/01/2025 and can validly claim priority to IT1 and the effective date
of the claims is the filing date of IT1 - A 89 EPC
·
If not and the correct
documents were merely submitted later within 2m from filing under R. 56a(3),
the application would be redated to the date when the correct documents were submitted
· This will be outside the 12m priority of IT1 and journal publication will be novelty-destroying 54(2) prior art
Further actions to get a patent for A in EP-1
· The wrong application documents (EP-2 descr and claims) will be maintained in the application as filed – R.56a(4)
·
The erroneously filed description
and claims must be removed during grant proceedings by amendment under Art.
123(2) – GL A-II, 6.4
·
Can only be done after receipt
of the search report – R 137(1)
·
NB: since the search fee was
paid at filing, it could be that the EPO has already started to draw up the
search report for the wrong claims.
·
If so, the EPO will invite the
applicant to pay an additional search fee under R. 56a(8) to be paid within 1m
b) Protection for B in EP-2
·
Since
the wrong application documents remain in the application as filed, EP-1 is the
first application for B
·
It
has an earlier filing date than EP-2 and, currently, would be
novelty-destroying 54(3) prior art of the claims of EP-2, after publication of
EP-1.
·
To
avoid this, add a priority claim to EP-1 under R. 52(2) EPC, within 16m from
earliest priority:
·
16/1/2024
+ 16m [R. 131(4)] à 16/5/2025 (Fri)
·
Pay filing and seach fee for
EP-2 until:
·
17/2/2025 + 1m -> 17/3/2025 (Mon)
·
Claim
to B in EP-1 must be deleted, to prevent double-patenting – G 4/19
QUESTION 3 (9 MARKS)
In appeal proceedings following the refusal of European
patent application EP-D filed by company D, the Board remitted the case for
grant based on a complete text which had been finally decided by the Board.
Within the time limit set by the communication under Rule
71(3) EPC received in November 2024, D requested an amendment, namely the
addition of a further dependent claim.
In a communication under Rule 112 EPC dated today (11
March 2025), D was informed that EP-D is deemed to be withdrawn.
(a) Why was the communication under Rule 112 EPC issued by the EPO?
(b) Can a patent be obtained with the complete text as decided by the Board and the additional dependent claim?
a) Rule 112 loss-of-rights communication was issued because:
· When a case is remitted for grant on the basis of a complete text which has been finally decided by the Board, under Art 111(1) EPC, it is not allowed to request further amendments under Rule 71(6) in view of Art. 111(2) EPC – GL E-XII, 9.
· The application was therefore deemed withdrawn under R 71(7) EPC
b) Yes
· It is possible to obtain a patent with the complete text as decided by the Board + additional dependent claim, but not via EP-D directly, as the Examining Division are bound by the Board’s ratio decidendi in this case – Art. 111(2) EPC.
· A divisional application needs to be filed - Art 76(1); R 36(1) – while EP-D is pending.
Actions
·
To restore pendency of EP-D,
request Further Processing within 2m of notification of R 112 communication –
Art. 121; R 135(1) EPC - by
· Complete omitted acts of R 71(3): pay fee for grant and printing – Rfees2(1)7 – file translation of claims into other 2 EPO languages, and
· Pay flat FP fee – RFees2(1)12
· After pendency is restored and at the latest on the day before the mention of the grant of EP-D:
· File divisional with Board-approved text + desired claims and
· Pay filing fee and search fee within 1m – R 36(3)
· After divisional is filed, withdraw EP-D to avoid double patenting – G4/19.
· The paid fee for grant and
publishing will then be refunded – Rule 71a(6)
· As approved by Board, claims of approved text are patentable.
· As a dependent claim (if allowable
under Art. 123(2), no information and if same effective date, no information)
is then also allowable, can proceed into examination and to grant.
QUESTION 4 (10
MARKS)
Company E filed an automatic debit order for its
international application PCT-E, for which the EPO is acting as International
Searching Authority (ISA). During the search phase, the ISA considers that the
claims of application PCT-E contain seven inventions and invites E to pay six
additional search fees.
(a) E is not interested in any of the additional inventions. Does E need to act?
(b) In order to enter the regional phase before the EPO, Form 1200 has been filed and all acts under Rule 159 EPC have been performed, except for paying the fees.
Will all fees for entry into the regional phase before the EPO be automatically debited?
Company F has an active automatic debit order for its European patent application EP- F, filed on 16 February 2020.
(c) EP-F was refused by the Examining Division. Company F filed an appeal against this decision on 28 February 2025. On this date, there were 3 000 EUR in the deposit account. Have any fees been automatically debited?
Company G filed a European patent
application EP-3 in February 2021,
together with an automatic
debit order for EP-3. The transfer of EP-3 to company H was registered with the
EPO in January 2025. EP-3 is still pending.
(d) Has the renewal fee for the fifth year been paid for EP-3?
Answer
a)
· The automatic debit order filed for PCT-E is valid as automatic debiting is allowed for all types of European and PCT proceedings (AAD, point 2.1), including additional search fees to be paid under PCT Art. 17(3)a within 1m from invitation [PCT R. 40.1(ii)] in the case of non-unity.
· Additional search fee not excluded in AAD point 3.2.
Action to avoid payment of 6 additional search fees:
· E needs to either revoke the ADO in Central Fee payment [AAD, point 10.1] or inform EPO as ISA that he is not interested in any of the additional six inventions, ...
· ... before the 1m period of PCT R. 40.1(ii) expires.
b)
·
The fees associated with EP
entry acts of R 159(1) EPC will not be automatically debited, because an
automatic debit order filed during the international phase has no effect in
proceedings before the EPO as designated or elected Office - AAD, point 2.2
·
A separate automatic debit
order must be filed for international applications entering the European phase. (AAD, point 2.2).
·
Or pay in another way, e.g.,
direct debit order ADA, via bank transfer or credit card central fee payment.
c)
·
Yes, appeal is also covered by
ADO when the appeal is filed by an applicant – AAD point 5.1
·
The fee for appeal is 2925
euros - RFees 2(1) 11, so there is sufficient money (3000 euros) on the deposit
account.
·
NB: 2925 euro is the maximum
amount; if the applicant is an entity under R 7a(2) EPC, the fee is reduced.
·
The appeal fee will be debited
when the notice of appeal is filed: AAD point 5.1(c)
·
Even if several automatic debit orders are pending on
that day, esp. the renewal fee, the appeal fee takes precedence and will be deducted first – AAD
point 4.5(a)
·
The renewal fee for the 5th
year is due on 28 Feb 2025 (Fr) - R 51(1) EPC.
·
Unless Applicant G has
explicitly revoked the AAD, EPO will continue to automatically debit fees from
the relevant deposit account, even in the event of a transfer (AAD, point
10.3).
·
Via automatic debiting, the
payment will have been deducted on the due date: 28 Feb 2025 (Fri) and has been
paid.
QUESTION 5 (11 MARKS)
In August 2024, applicant I filed international application
PCT-I in English with the Swedish Intellectual Property Office, specifying that
office as ISA.
PCT-I has two independent claims directed to inventions C
and D. C and D are not linked by a single general inventive concept.
Last week, applicant I received an invitation to pay an
additional search fee for invention D.
What are the options if applicant I wants to have the EPO
carry out an international preliminary examination only for invention
D in PCT-I? What steps need to be taken and
why?
·
The EPO will act as IPEA when the Swedish office has been ISA - EPO-WIPO agreement Art 3(2), OJ 2017 A115
· The EPO as IPEA will not examine unsearched claims - PCT-EPO GL, C-V, 1
· EPO is competent IPEA when an invention is searched by EPO itself or a number of selected other offices including the Swedish patent office (Art. 32(2) PCT, EPO-WIPO Agreement (OJ EPO 2017, A115, Art. 3(2))).
· Thus, EPO can be
IPEA when invention D has been searched by the Swedish office (option 1) or by
the EPO (Option 2)
Option 1
·
The applicant should pay the
additional search fee for D within 1m from invitation [ R. 40.1(ii) PCT], such
that the ISR established under Art 17(3)a PCT covers C and D
Option 2
·
EPO can search Inv. D as SISA,
because SE Office is ISA – R. 45bis.9
· File request for SIS at IB [R. 45bis.1
(b)], indicating EPO as SISA and pay the SIS fee for EPO as SISA and a handling
fee within 1m from request [R. 45bis.2(c) and R. 45bis.3(c)].
· Indicate that claims directed to inv D are
to be searched – R. 45bis.1(d)
· The EPO as SISA will then limit the SIS to
inv D - R.45bis.5(b)
·
File a demand directly with the
EPO as IPEA. – Art. 31(6) PCT
·
Time limit: later of 22m from
priority or 3m from transmittal of ISR – R 54bis.1(a) PCT
·
Together with the demand, the
applicant should file claim amendments under Art 34 directed to invention D.
·
Pay the preliminary examination
fee and handling fee to the EPO within 1m of submitting the demand or no later
than 22m from priority to avoid a surcharge – R. 57.3(a) jo R. 58.1(a)
·
When the EPO is also SISA, it
is possible to file a demand under Chapter II with the EPO and additionally a
request for SIS by the EPO; the examiner will first establish the SISS and then
continue with Chapter II – PCT-EPO GL B, XII, 11
Re question 3:
ReplyDeleteI responded along the lines of the solution above (missing some marks here and there), but, as an after thought, would the divisional application have issues of double patenting? The question is the same claim set with new dependent claims, indicating that the independent claims will be identical. I can see the divisional being granted with an independent claim constituted by the original independent claim + the new dependent claim, as that would create a difference in scope.
The main claim in both would be identical, so that would constitute double patenting
Delete@Gb: G 4/19 is very explicit that it is not about same scope, but about "claims the same subject-matter". But note that even if it was bout scope: the independent claims are the same, so have the same scope - dependent claims by their definition (GL F-IV, 3) do not change the scope of protection conferred by the patent (and are in principle not needed; we have them for fallback and for secondary reasons).
DeleteIn question 1, should you also withdraw the EP priority application to prevent it from becoming prior art under art 54(3) after publication?
ReplyDeleteI thought the same. Following through: withdrawing EP-B causes a loss of the better effective date of EP-B which seemed to risky for me.
DeleteInstead I went for proposing deferring EP entry using FP on all required acts for EP entry. Any thoughts about this?
I went for the same strategy as J. In 'real life' I can't imagine being confident enough to tell my client to withdraw a priority claim! I also suggested using FP, though noted that they should do all of the R159 requirements except one to avoid having to file FP requests for each omitted act.
DeleteThe question does not say anything about subject matter disclosed/claimed or intended to be covered by either application and the question also only asks how to defer entry to the max, so advising to withdraw EP-B based on the information given would go a little far in my opinion
DeleteI also suggested using FP, and then choosing which acts to do by 31m deadline, and which acts to omit to minimise FP fees. Removing priority claim seems like a one way ticket to losing ALL of your rights! How anyone suggesting this to a client as a first option is fit to practice is confusing...
DeleteJS - if you wanted to defer EP entry as much as possible, why not suggest withdrawing both applications and then re-filing a new application 5 years later?
DeleteDear Sigrid, you are right. Can't believe we all missed that. Indeed, the EP priority application must be withdrawn before it publishes, which will occur shortly after expiry of the 18m period of Art. 93(1)a EPC. The withdrawal request must be submitted before the technical preparations for publication are complete - R 67(2) EPC.
DeleteTechnical preparations are deemed complete 5 weeks before expiry of 18m period:
So on 5 April 2025 - R 67(1); OJ 2007, SE3 D.1
EP priority must be withdrawn before this date to guarantee non-publication.
Request for withdrawal should be signed by the applicant: Mr B only in this case.
We will modify our answer
AD - because the question states that A and B wish to delay the entry of PCT-AB into the European phase, FP can be used on top of the withdrawn priority claim. With regards to EP-B I only mean to say that in my opinion advise to withdraw EP-B goes too far for lack of further information and goes beyond the scope of the question. However, pointing out the issue of EP-B becoming prior art after a hypothetical publication in the response to Q1 is certainly not wrong/will quite possibly be worth some marks
Deletewithdrawing the priority in this initial situation with only A documents seems far too risky to me. if this goes wrong, it could even give rise to a claim for damages.
Delete@Anomymous: if so, you need to give convincing arguments - A documents are not a problem (unless there are facts given that show that they are, e.g., they may be if claims are unclear).
DeleteHere, you have all the facts that show you risk: EP-B itself!
There may be a risk that unknown but relevant prior art shows up (not mentioned in EESR) when priority is withdrawn.
DeleteThe question does not mention the date of issuance of the search report but normally the EPO strives to issue the extended European search report within six months from the filing date (GL E-VIII, 4.1), so EP-B report likely does not cover a period of about 6 months before the filing of PCT-AB; even 54(2) prior art could exist within that period if the priority is withdrawn.
DeleteHello J I also went for the FP route.
ReplyDeleteI also went with the FP route... Technically though I guess withdrawing the priority claim is the best way to delay the entry for the longest time, but I agree with J and Kate that withdrawing a priority claim feels incredibly risky... Very glad to see that I wasn't the only one going with FP though, even though I would assume that withdrawing priority is the right answer. Let's hope we get at least some points for our solution
ReplyDeleteFrom a client advise perspective, it felt also incredibly risky to me. Sure, if the client would only be interested in a national/regional phase outside of EP, dropping the priority claim is okay bc EP-B would not form prior art after publication.
DeleteAs the question states to delay the entry "as long as possible", in my opinion, withdrawing the priority claim is the right answer. However, such an advise is far away from normal patent practise. I wouldnt recommend such a solution to my client.
DeleteI also went with FP as the primary route. I mentioned withdrawing the priority claim, but only to discuss the potential issues.
DeleteI also went for the FP route. I thought "The European search report for EP-B cites only A documents." was a pointer to not throwing away priority since your position in terms of patentability can only get worse.
Delete@Lena: I do not agree. That those documents are classified as A means that they are only background and not relevant and hence suggest that you can safely withdraw the priority claim. However, this question is kind of a warning if you consider to do that: there may be 54(3)'s that the EPO did not yet cite and that you are not aware of - or that you can actually even be aware of as in this case (EP-B). The mention of the A documents is a trigger to check the effect of withdrawal on the prior art situation, and on patentability. (Unfortunately, the explicit question is just asking for procedural steps to be taken and why and may be understood as procedural steps needed to delay the entry and you may overlook that they also want you to take the procedural step of wirhdrawing EP-B before publiction)
DeleteIf you withdraw the priority of EP-B would this not become prior right for the later Euro-PCT application?
ReplyDeleteQ3: I didn't realise further processing would be available here, since the notification seemed to be triggered by the filed amendments, not because of a missed time limit. I suggested asking for a decision according to R. 112(2), appealing the decision, and filing the correct response to the 71(3), and then proceeding with a divisional.
ReplyDeleteJohanna: Q3. The EPO acted in accordance with the Guidelines, i.e. they did nothing wrong, so no grounds for requesting an appealable decision under R 112(2). NB: I did wonder about it too when I sat the exam yesterday as a benchmarker.
DeleteThank you Diane, that does make sense for why appeal is not an option. But why is FP an option? The applicant didn't fail to observe a time limit, they filed an amendment that triggered a loss of rights.
DeleteI've been thinking along the same lines as you, Johanna. And I assumed that an interlocutory revision (A 109) would happen by accepting the claims as initially accepted by the Appeal Board.
DeleteJohanna - I think the loss of rights was triggered by failure to pay grant fee and file translations within 4 months of the 71(3) communication, not because of the amendment. Since the amendment was not allowed, it is not related to the loss of rights (more than in that the loss wouldn't have been triggered if it was allowed as it is usually)
Delete@Erik We don't actually know that the time limit to pay grant fee and file translations was missed. The R. 71(3) was received at some point in November (no date given), so the deadline for those acts expires at some point in March. We would have to assume that the R. 71(3) was received in the first few days of November for the deadline to expire early in March and the associated LoR to be dated 11 March. On the other hand, we know from the GL procedure and answer to part (a) that filing amendments after appeal triggers an LoR. It doesn't make sense to me, based on the given facts, to assume that the LoR relates to failure to pay the grant fee and file translations since we don't know that that period even expired yet.
DeleteI read through the T decision and found the following: In the Board's view, the patent application is also deemed to be withdrawn under Rule 71(7) EPC if the applicant - without taking the actions required under Rule 71(3) EPC - within the time limit of Rule 71(3) EPC
DeleteThe request under 71(6) is simply ignored as it is inadmissible.
I suppose we have to conclude that the required response was not filed within the 4m time limit of R 71(3), but I agree that this could have been clearer.
@Johanna: Good question, it is subtle:
DeleteGL E-XII,9 says “If the applicant requests further amendments under Rule 71(6), the application will be deemed withdrawn under Rule 71(7) as the procedure under Rule 71(6) cannot be applied in view of Art. 111(2).”
Rule 71(7) reads “(7) If the fee for grant and publishing or the claims fees are not paid in due time, or if the translations are not filed in due time, the European patent application shall be deemed to be withdrawn. “
So, it is considered a missed time limit.
R.71(7) is not excluded from FP - R.135(2).
So FP is available.
Regarding interlocutory revision: before the 2018 T decision on which the current Guidelines is based, there is an older decision from 2012 where the application got refused under A 97(2) in similar circumstances. This is an appealable decision that could be fixed by filing and appeal and doing what was required. interlocutory revision would have been possible.
DeleteBut EPO practice has changed
I guess I thought about it as "if applican't requests amendments according to 71(6) INSTEAD of paying the fees and filing translations according to 71(3)..." but I realize that it doesn't say so explicitly at all, which it usually does in the guidelines... now it feels more unclear than I thought before. Question for the experts - what would happen if applicant first replied with amendments according to 71(6), realized the mistake and then paid fees and filed translations before the 4 month deadline?
Delete@Erik: tRule 71(3) is the INVITATION, not the response thereto. The possible, alternative responses to the invitation are given in 71(5) for approval, 71(6) for disapproval and 71(7) for non/incomplete reponse. -- see also actual Rule 71(3) invitations which specify the alternatives very clearly (checking how invitations that are listed in the EPC look like in real-life cases is always a good idea - we show many in our courses as they are often very clear!).
Delete71(5), (6a) and (7) are address in the Guidelines in consecutive paragraphs in C-V: C-V, 2, C-V, 4 and C-V, 3 resp.
DeleteI guess I'll have to rely on D2.
ReplyDeleteFor having studied so much, I’m really bummed with the actual D1 results. Where do they find these exotic questions? On the upside, D2 went surprisingly smooth, so I hope that it well level out to 45 or more in the end.
ReplyDeleteI had the same experience. I was not expecting this type of questions at all. Particularly on AAD. I was expecting questions on R7a and UPC. D2 went also much better for me.
DeleteR.7a was also on my list as a candidates, but probably this D1 came just a bit too early, as the Guidelines (2024) do not have it in. Expect it next year!
DeleteAlways be prepared for ADA and AAD. More than 95% of the payments are done that way and they are in D1 or D2 every few years - usually in a more difficult version that this year: thus year, each of questions a-d were very short and directly directed to just a single AAD provision (or a few closely related related ones) and not in the context of a more complex case where you had to also consider other legal aspects. But... ADA/AAD questions are always perceived difficult by candidates, irrespective of their "objective difficulty".
DeleteFor ADA/AAD, one needs to be aware that they change relatively often and that the GL may refer to outdated versions. In this D1, the relevant GL are the 2024 GL which still refer to the 2022-version in OJ Suppl 3/2022 (e.g., in E-X, 4.2.1), while the relevant version is the 2-24-version of OJ 2024, Suppl 2/2024 (valid as of 12 April 2024) - luckily the changes were not really relevant for this particular question. ;)
I had problems answering question 2 as i think it is not possible to replace the entire description under R.56, e.g J27/10. So i have written that it is not possible which is a bit underwhelming
ReplyDeleteI went to a wrong direction as well…the priority was invalid due to the different inventions and a new application with correct disclosure can be filed within the priority period…
Delete@Anonymous (please use a name):
DeleteNot under R.56, but under R.56a!
For question 2b) I suggested filing a divisional from EP-1 disclosing A only and then withdrawing EP-1 before publication.
ReplyDeleteThis sounds like a valid option to get protection for invention A, whilst removing EP-1 as novelty destroying prior art for EP-2, albeit with an additional cost of filing the divisional. It could be even argued that if the search for EP-1 has not yet started, a request for refund of the search fee for EP-1 could be submitted.
DeleteNote that also without such request, the search fee for EP-1 will be refunded if withdrawn before it started - see RFees 9(1)
DeleteRegarding Question 3. Does everyone found the right source for argumentation in GL E-XII, 9? All of my books doen't cite the GL here. So I didn't found it during the paper.
ReplyDeleteI found it in the guidelines - by opening the XII- appeals tab, there was a section called "remittal". So it went quite quick. But I didn't manage to solve the problem of how to obtain patent with the additional dependent claim. I answered that it is not possible, but suspected already then that it is probably not the right answer as the question was worth 9 points and cannot merely be that section in GL only... However, at that point, I was really low on time.
DeleteI think there are two ways to find GL E-XII, 9 relatively easily:
Delete1) If you are well-familiar with the structure of the Guidelines, you know or can find quicvkly that Part E has a chapter XII on appeals. That part has table of contents that shows a section 9 titled "9. Remittal to the examining or opposition division after appeal";
2) If you use the "Topic-Related Index to the EPC and PCT" book, you find in the keyword index "Appeal" -> "Decision of the board" -> "Remittal to the department of first instance" directing you to page 168 (2024 edition) . On that page, the table directs you to Art. 111(1) and (2) as well as GL E-XII, 9 and also indicates that "That department is bound by the ratio decidendi of the board".
I want to add to Question 4 c):
ReplyDeletesince the EP-1 was filed on 16. Feb. 2020. The fourth renewal fee is due on 28. Feb. 2020. So the appeal fee is depited first, AAD 4.5, and the remaining 75€ (3000€ - 2925€, Rfees 2(1).11) are not sufficient for the renewal fee. The applicant will get an notification acc. to ADA 7.4.1 last sentence. Right?
*was due on 28.Feb.2025
DeleteI noticed the renewal fee at the very last moment, and did not have the time to discuss it in full. The situation seems to be more complex than what you mentioned. Because there are two fees due, with a total exceeding 3000 euro, it would seem that no payment will be made on 28 February until the deposit account is duly replenished (Point 6 AAD - "shortfall"). The account holder will be informed by email or post (Point 6 AAD). Once replenished (Point 7 AAD), the appeal fee will be paid first indeed (Point 7.4.2 ADA, Point 4.5 AAD), as you mentioned. So much stuff to take into account and cite ...
DeleteArguably, the renewal fee could still be paid within 6 months from 28 February with an additional fee (R.51(2) EPC). Not sure if there would be kind of fail safe in the specific case of renewal fees, so that the appeal fee would get actually paid on 28 February. Food for thought.
Well, sounds indeed complex. But since they mentioned the filing date I am sure they expected a discussion about the renewal fee.
DeleteI am not sure how 6 should be interpreted (or,if you want, how is applied in practice). Is it indeed that no fee is booked at all, or would the fees be booked in the order referred in point 4.5 (also mentioned in point 6, shortfall)?
DeleteWhy is there an order of payment of the fees as long as sufficient funds are available in 4.5 if no fee is booked at all because the total fees to be booked exceed the available funds?
"Individual fees are booked in the following order of priority, for as long as sufficient funds are available:
(a) appeal fee (011)
(b) all other fees in ascending order of their fee codes."
I believe discussion of the renewal fee was expected,otherwise the filing date would be pointless, but I wonder now what would be the conclusion re the appeal fee...
Q.4x says “Company F filed an appeal against this decision on 28 February 2025. On this date, there were 3 000 EUR in the deposit account.” So, as appeal fee gets precedence, it is paid then, when the notice of appeal is files. That the renewal fee is due on the same date has no effect on the payment of the appeal fee. The renewal fee may still be paid with additional fee within 6m, before its non-payment results in a deemed withdrawal - R.51(2)
DeleteAnswer to 3b is painful... prosecuting basically identical patent again including paying all fees and FP fees and for what... to get a patent with same scope of protection as the parent but an extra dependent clam? Solution feels a bit far fetched tbh
ReplyDelete@Edit: I tend to agree, but Rule 22(3) IPREE tells is to accept the facts… with those, the question can be answered. (Whether they expected to also include FP or not is not clear to me; I did include it, but whether they really wanted it…)
DeleteStill puzzled by the strange situation in Q.3. We shall not question the facts (Rule 22(3) IPREE), so we need to answer the question as it is posed, and we can: it seems clear what the answer to the question shall be and what they would all expect in that answer.
ReplyDeleteBut... does anyone have any idea why one would want to add of a further dependent claim at this stage?
Note that the answer uses the divisional to get the amended claim, which will work. But if the applicant would have responded to the Rule 71(3) (if there would not have been the appeal) with an amendment adding a dependent claim, it would likely not be admitted in view of Rule 137(3) EPC and GL C-V, 4.4 and H-II, 2.5 and subsections...
Neutralisation?
DeleteNo idea. I wasted quite a bit of time to check the question in all three languages, because I thought there was sth. missing. I do not see any reason to delay the grant of a patent and to spent the costs and effort for a divisional just to add a dependent claim... I assume there is no way to add an additional dependent claim via Art 105a after grant?
Delete@Jaques: no, not via 105a. See GL D-X, 4.3: “Likewise, adding dependent claims in limitation is not permissible if not directly caused by the limitation introduced in the claims.”
Delete